Does iron reduction improve sustained viral responses to interferon monotherapy in hepatitis C patients? Maybe, but is this the right question?

about

Does iron reduction improve sustained viral responses to interferon monotherapy in hepatitis C patients? Maybe, but is this the right question?

Item

http://www.wikidata.org/entity/Q43037872

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Does iron reduction improve su ...... ut is this the right question?

@en

Does iron reduction improve su ...... ut is this the right question?

@nl

type

Item

label

Does iron reduction improve su ...... ut is this the right question?

@en

Does iron reduction improve su ...... ut is this the right question?

@nl

prefLabel

Does iron reduction improve su ...... ut is this the right question?

@en

Does iron reduction improve su ...... ut is this the right question?

@nl

P1476

Does iron reduction improve su ...... ut is this the right question?

@en

P2093

Steven I Shedlofsky

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin.

A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.

Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome.

Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.

Liver iron accumulation in chronic hepatitis C patients without HFE mutations: relationships with histological damage, viral load and genotype and alpha-glutathione S-transferase levels.

Associations between cellular immune effector function, iron metabolism, and disease activity in patients with chronic hepatitis C virus infection.

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy.

Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C.

P304

1093-1096

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/J.1572-0241.2002.05701.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12014712

http://www.w3.org/2001/XMLSchema#string